“Paradigm shift”: What success of a new honeybee vaccine means for veterinarians
AAHA
Last updated: May 2, 2026
Dalan Animal Health has achieved a historic milestone with its vaccine for poultry, receiving conditional licensure from the U.S. Department of Agriculture (USDA) in 2022. This marks the first-ever approval of a vaccine for an insect in the United States, opening new avenues for disease prevention and control in agricultural settings. The vaccine targets the varroa mite, a significant pest affecting honeybee colonies.
- Dalan Animal Health's innovative vaccine, conditionally licensed by the USDA in 2022, is the first of its kind approved in the United States for an insect pest.
- The vaccine is specifically designed to combat the varroa mite, a destructive parasite that poses a severe threat to honeybee populations globally.
- This development represents a significant advancement in apiculture and pest management, offering a new tool for beekeepers to protect their colonies.
- The conditional licensure indicates that the vaccine has undergone rigorous evaluation and shows promise in addressing a critical agricultural challenge.
- The approval is expected to have substantial implications for bee health and the broader agricultural industry, which relies heavily on pollination services.
- Further research and implementation will be crucial in assessing the full impact of this groundbreaking vaccine.
